| Association of HIV-1 Gag with the luminal domains of lysosomal-associated membrane protein (LAMP-1) rgulates gag expression and antibody production in a mice DNA vaccination model |
|
2009 |
| Development of a new strategy for an anti-HIV vaccine based on the use of primary dendritic cells trasnfected with LAMP/gag chimeric plasmids |
|
2009 |
| Role of B lymphocytes on dengue virus infection. |
|
2009 |
| Infection of endothelial cells with dengue virus in the presence of bradykinin modulates NO production, viral replication and expression of adhesion molecules. |
|
2009 |
| ? ?Luminal domain of lysosomal associated membrane protein-1 (LAMP-1) associated with Gag HIV-1 regulates its expression and specific antibody production in a mice DNA vaccination model ?Godinho, RMC, Lucas, CGO, Goldoni, AL, Sato, MN, Marques Jr. ETA, Arruda, LB. |
|
2009 |
| The role of B lymphocytes on dengue virus infection |
|
2009 |
| Bradykinin and angiotensin-(1-7) modulate nitric oxide production and dengue virus infection in human brain microvascular endothelial cells |
|
2008 |
| Cholesterol and sphingolipids are involved in human cellular infection by dengue virus |
|
2008 |
| Mechanisms of human B cell activation and antibody secretion induced by dengue virus |
|
2008 |
| Study of primary dendritic cells transfected with Lamp/gag and DC-LAMP/gag as a potential anti-HIV vaccine |
|
2008 |
| Association of HIV-1-Gag with the luminal domain of lysosomal associated membrane protein (LAMP-1) regulates Gag expression and antibody production in a mice DNA vaccination model |
|
2008 |
| Study of the mechanisms of human B lymphocytes activation by Dengue virus serotypes 2 and 3 |
|
2007 |
| Curcumin inhibits B cell activation induced by TLRs |
|
2007 |
| Inhibition of B cell signaling by in vitro treatment with the alkaloid wariftein isolated from Cissampelos sympodialis |
|
2007 |
| Dengue virus induces polyclonal Ig secretion by primary human B lymphocytes |
|
2007 |
| ? Dengue virus replication and induction of nitric oxide in human endothelial cells are modulated by bradykinin and angiotensin 1-7 |
|
2007 |
| ? Bradykinin and angiotensin-(1-7) enhance Sindbis virus infection of brain microvascular endothelial cells by delaying virus-induced apoptosis |
|
2007 |
| cAMP-dependent inhibition of Bcell response by wariftein |
|
2006 |
| Modulation of human B lymphocyte activation by dengue virus |
|
2006 |
| The role of membrane microdomains in human cellular infection by dengue virus |
|
2006 |
| · Bradykinin adjuvant converts epimastigote extracts into protective immunogens by driving effector-memory T cell differentiation via IL-12 instructive pathway |
|
2005 |
| ? Inhibition of B cell response by wariftein purified from the extract of Cissampelos sympodialis EICHL (Menispermaceae) |
|
2005 |
| Expression of functional TLR4 confers higher resistance to infection with Trypanosoma cruzi |
|
2004 |
| Bradykinin-driven activation of dendritic cells: new strategies for adjuvant development and vaccine production |
|
2004 |
| Modulation of B lymphocyte response by wariftein purified from the extract of Cyssampelos sympodialis |
|
2004 |
| Different HIV-Gag Cellular Trafficking Mediated by LAMP-gag and DC-LAMP/gag DNA Chimeras Influences the repertoire of Activated T and B Cells |
|
2004 |
| Induction of high levels of HIV-Gag expression and immune response elicited by lysosomal associated membrane protein (LAMP) luminal domain in LAMP/Gag DNA vaccine chimeras. |
|
2003 |
| DNA encoding a HIV-1 Gag/lysosome-associated membrane protein (LAMP) chimera elicits strong B- and T- cell Gag-specific immune responses in rhesus monkeys |
|
2003 |
| Modulation of Epitope Presentation by Differential Trafficking to Antigen Processing Compartments: Application to HIV Vaccine Development |
|
2003 |
| Towards rational HIV vaccine design: targeting HIV-Gag to different antigen processing compartments results in modulation of Gag-specific T cell repertoire |
|
2003 |
| Different HIV-Gag Cellular trafficking mediated by LAMP/gag and |DC-LAMP/gag DNA chimeras influences the repertoire of activated T and B cells |
|
2003 |
| AAV delivery of a LAMP/p55Gag vaccine chimera |
|
2002 |
| Curcumin effects in murine B lymphocytes |
|
2001 |
| Modulation of B lymphocyte function by NK cells activated with GIPL derived from Trypanosoma cruzi. |
|
2000 |
| Modulation in vitro of Trypanosoma cruzi infected mice B cell response by the hidroalcoolic extract of the Cissampelos sympodialis |
|
1999 |
| Inhibition of human B cell function by Curcumin |
|
1999 |
| Stimulatory effect of the glycoinositolphospholipid purified from Trypanosoma cruzi |
|
1998 |
| Immunoglobulin production by Trypanosoma cruzi-infected mice: the role of B lymphocyte-natural killer (NK) cell interaction |
|
1997 |
| B cell and natural killer cell activation induced by glycoinositolphospholipids purified from Trypanosoma cruzi |
|
1997 |
| Glycoinositolphospholipids (GIPLs) purified from Trypanosoma cruzi stimulate huma natural killer cells |
|
1996 |
| Human natural killer cell induced by Trypanosoma cruzi-derived glycoinositolphospholipids |
|
1996 |
